Section one: Contracting authority
one.1) Name and addresses
Department of Health and Social Care
39 Victoria Street
London
SW1H 0EU
Contact
Procurement Operations
procurement.operations@dhsc.gov.uk
Country
United Kingdom
Region code
UKI32 - Westminster
Internet address(es)
Main address
https://www.gov.uk/government/organisations/department-of-health-and-social-care
Buyer's address
https://www.gov.uk/government/organisations/department-of-health-and-social-care
one.4) Type of the contracting authority
Ministry or any other national or federal authority
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Pandemic Resilience, Supply & R&D Agreement for mRNA vaccines
two.1.2) Main CPV code
- 33651600 - Vaccines
two.1.3) Type of contract
Supplies
two.1.4) Short description
The contract is to establish UK-based mRNA vaccine development and manufacturing capability to support the UK's preparedness and resilience for future pandemics and health emergencies. The objective of security of supply in such circumstances is to be met by the construction of a mRNA manufacturing facility sited within the UK which will work alongside UK-based fill/finish providers to supply vaccines. In addition, the contract also includes certain commitments for the supplier to invest in R&D in the field of mRNA vaccines and therapeutics within the UK.
two.1.6) Information about lots
This contract is divided into lots: No
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £1
two.2) Description
two.2.2) Additional CPV code(s)
- 73300000 - Design and execution of research and development
- 33651600 - Vaccines
- 73300000 - Design and execution of research and development
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
The contract is to establish UK-based mRNA vaccine development and manufacturing capability to support the UK's preparedness and resilience for future pandemics and health emergencies.
two.2.5) Award criteria
Price
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
Contract value is being withheld due to commercial sensitivity (Reg 50(6)(b) and (c)). Publication may enable competitors to calculate cost per dose. This will commercially prejudice:
(i) the supplier in its negotiations with other national governments
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Award of a contract without prior publication of a call for competition in the cases listed below
- The procurement falls outside the scope of application of the regulations
Explanation:
The contract has been awarded under the exclusion in Regulation 15 (Defence and security) of the Public Contracts Regulations 2015. The contract is for protection of the essential security interests and resilience of future United Kingdom pandemic preparedness. The award follows the Authority's press announcement in June 2022 (https://www.gov.uk/government/news/moderna-to-open-vaccine-research-and-manufacturing-centre-in-uk) that it had entered into an agreement in principle with Moderna for the strategic partnership. The Authority is not obliged under the UK public procurement regulations to follow a statutory procurement process because Regulation 15(2)(a) (essential security interests of the UK) of the PCR 2015 applies. This notice is therefore being published on a voluntary basis. Nothing in this notice, nor in its publication, implies any intention or gives rise to an obligation to enter into a statutory procurement process under the UK public procurement regulations.
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
Section five. Award of contract
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
20 December 2022
five.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
MODERNA BIOTECH UK LIMITED
54 Portland Place, London, W1B 1DY
London
W1B 1DY
Country
United Kingdom
NUTS code
- UK - United Kingdom
National registration number
11990046
The contractor is an SME
Yes
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £1
Lowest offer: £1 / Highest offer: £1 taken into consideration
Section six. Complementary information
six.4) Procedures for review
six.4.1) Review body
The High Court
The Strand
London
WC2A 2LL
Country
United Kingdom